Some notes on crystallizing fibrinogen and fibrin fragments

Biophysical Chemistry

Volumn 100, Issue 1-3, 2002, Pages 307-313

  Doolittle, Russell F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crystal structures; Fibrin; Fibrinogen; Trimethylamine oxide

Indexed keywords

FIBRIN; FIBRINOGEN; SYNTHETIC PEPTIDE; THROMBIN; TRIMETHYLAMINE OXIDE;

CHICKEN; CRYSTALLIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

EID: 0037438336     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(02)00288-0     Document Type: Article

References (33)

1. Edsall J.T. The plasma proteins and their fractionation. Adv. Protein Chem. 3:1947;383-479.
2. Doolittle R.F., Oncley J.L., Surgenor D.M. Species differences in the interaction of thrombin and fibrinogen. J. Biol. Chem. 237:1962;3123-3127.
3. Edsall J.T., Wyman J. Biophysical Chemistry, vol. 1. 1958;Academic Press, New York.
4. Morrison P.R., Edsall J.T., Miller S.G. Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma. J. Am. Chem. Soc. 70:1948;3103-3108.
5. Shulman S. The conversion of fibrinogen to fibrin. IV. Reversible inhibition of the reaction. Arch. Biochem. 30:1951;353-3371.
6. Doolittle R.F. Structural aspects of the fibrinogen-to-fibrin conversion. Adv. Protein Chem. 27:1973;1-109.
7. Edsall J.T., Foster J.F., Scheinberg H. Studies on double refraction of flow. III. Human fibrinogen and fraction I of human plasma. J. Am. Chem. Soc. 69:1947;2731-2788.
8. Edsall J.T. Configuration of certain protein molecules. An inquiry concerning the present status of our knowledge. J. Polym. Sci. 12:1954;253-280.
9. Hall C.E., Slayter H.S. The fibrinogen molecule: its size, shape and mode of polymerization. J. Biophys. Biochem. Cytol. 5:1959;11-17.
10. Cohen C. Invited discussion at symposium on protein structure. J. Polym. Sci. 49:(1961):1960;144-145.
11. Tooney N.M., Cohen C. Microcrystals of a modified fibrinogen. Nature. 234:1972;23-25.
12. Ferry J.D. The mechanism of polymerization of fibrin. Proc. Natl. Acad. Sci. USA. 38:1952;566-569.
13. Laudano A.P., Doolittle R.F. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry. 19:1980;1013-1019.
14. Shimizu A., Nagel G., Doolittle R.F. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to γ-chain residues 337-379. Proc. Natl. Acad. Sci. USA. 89:1992;2287-2892.
15. Yamazumi K., Doolittle R.F. Photoaffinity labeling of the primary fibrin polymerization site: localization of the label to γ-chain Tyr-363. Proc. Natl. Acad. Sci. USA. 89:1992;2893-2896.
16. Kuyas C., Haeberli A., Walder P., Straub P.W. Isolation of human fibrinogen and its derivatives by affinity chromatography on Gly-Pro-Arg-Pro-Lys Fractogel. Thromb. Haemostasis. 63:1990;439-444.
17. Yamazumi K., Doolittle R.F. The synthetic peptide Gly-Pro-Arg-Pro-amide limits plasmic digestion of fibrinogen in the same fashion as calcium ion. Protein Sci. 1:1992;1719-1720.
18. Everse S.J., Pelletier H., Doolittle R.F. Crystallization of fragment D from human fibrinogen. Protein Sci. 4:1995;1013-1016.
19. Haurowitz F. Das Gleichgewicht zwischen Hämoglobin und Sauerstoff. Hoppe-Seyler Z. Physiol. Chem. 254:1938;266-274.
20. Doolittle R.F., Everse S.J., Spraggon G. Human fibrinogen: anticipating a three-dimensional structure. FASEB J. 10:1996;1464-1470.
21. Rao S.P.S., Poojary D., Elliot B.W., Melanson L.A., Oriel B., Cohen C. Fibrinogen structure in projection at 18 Å resolution. electron density by co-ordinated cryo-electron microscopy and X-ray crystallography. J. Mol. Biol. 222:1991;89-98.
22. Spraggon G., Everse S.J., Doolittle R.F. Crystal structures of fragment D from human fibrinogen and its cross-linked counterpart from fibrin. Nature. 389:1997;455-462.
23. Yee V.C., Pratt K.P., Cote H.C., et al. Crystal structure of a 30-kDa C-terminal fragment from the γ-chain of human fibrinogen. Structure. 5:1997;125-138.
24. Everse S.J., Spraggon G., Veerapandian L., Doolittle R.F. Conformational changes in fragments D double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry. 38:1999;2941-2946.
25. Yang Z., Mochalkin I., Doolittle R.F. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc. Natl. Acad. Sci. USA. 97:2000;14156-14161.
26. Brown J.H., Volkmann N., Jun G., Henschen A.H., Cohen C. The crystal structure of modified bovine fibrinogen. Proc. Natl. Acad. Sci. USA. 97:2000;85-90.
27. Yang Z., Mochalkin I., Veerapandian L., Riley M., Doolittle R.F. Crystal structure of a native chicken fibrinogen at 5.5 Å resolution. Proc. Natl. Acad. Sci. USA. 97:2000;3907-3912.
28. Doolittle R.F., Thomas C., Stone W. Jr. Osmotic pressure and aqueous humor formation in dogfish. Science. 137:1960;36-37.
29. Yancey P.H., Somero G.N. Methylamine osmoregulatory solutes of elasmobranch fishes counteract urea inhibition of enzymes. J. Exp. Zool. 212:1980;205-213.
30. Yang Z., Kollman J.M., Pandi L., Doolittle R.F. Crystal structure of a native chicken fibrinogen at 2.7 Å resolution. Biochemistry. 40:2001;12515-12523.
31. Brown C.R., Hog-Brown L.Q., Biwersi J., Verkman A.S., Welch W.J. Chemical chaperones correct the mutant phenotype of the ΔF508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones. 1:1996;117-125.
32. Lin T.Y., Timasheff S.N. Why do some organisms use a urea-methylamine mixture as osmolytes? Biochemistry. 33:1994;12695-12701.
33. Baskakov I., Bolen D.W. Forcing thermodynamically unfolded proteins to fold. J. Biol. Chem. 273:1998;4831-4834.